News

Filter

Current filters:

Analgesia

1 to 9 of 30 results

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

09-01-2015

UK-based GW Pharmaceuticals and Japanese drugmaker Otsuka have reported that Sativex (nabiximols) did…

AnalgesiaGW PharmaceuticalsOncologyOtsuka PharmaceuticalPharmaceuticalResearchSativexUKUSA

Zynerba Pharmaceuticals appoints Richard Baron as vice president and chief financial officer

Zynerba Pharmaceuticals appoints Richard Baron as vice president and chief financial officer

05-01-2015

Synthetic cannabinoid specialist Zynerba Pharmaceuticals has appointed Richard Baron as vice president…

AnalgesiaBoardroomPharmaceuticalUSAZynerba Pharmaceuticals

Durect to ‘refine the path’ of Posidur program

Durect to ‘refine the path’ of Posidur program

12-11-2014

US drugmaker Durect Corporation says that it has received meeting minutes from its face-to-face meeting…

AnalgesiaDurectPharmaceuticalPosidurRegulationUSA

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

24-10-2014

The acute pain market will experience only minimal growth between 2013 and 2023, according to biopharma…

AnalgesiaCelebrexDecision Resources GroupMarkets & MarketingPharmaceutical

Novartis is fined by Indian pricing authority over Voveran

Novartis is fined by Indian pricing authority over Voveran

14-10-2014

Swiss pharma major Novartis has received a penalty charge of 3 billion rupees from the Indian National…

AnalgesiadiclofenacIndiaLegalNovartisPharmaceutical

Yale's Stephen Waxman to collaborate with Convergence Pharmaceuticals on chronic pain

Yale's Stephen Waxman to collaborate with Convergence Pharmaceuticals on chronic pain

06-10-2014

Convergence Pharmaceuticals Holdings, focused on developing analgesic medicines, is to collaborate with…

AnalgesiaBiotechnologyConvergence PharmaceuticalsResearchUK

Relmada appoints Julie Chen as Director of Finance and Operations

02-10-2014

US pain therapeutic specialists Relmada Therapeutics has appointed Julie Chen as its Director of Finance…

AnalgesiaBoardroomPharmaceuticalRelmada TherapeuticsUSA

Actavis files ANDA for generic of Purdue's Butrans

Actavis files ANDA for generic of Purdue's Butrans

26-09-2014

Ireland-headquartered generics major Actavis has filed an Abbreviated New Drug Application with the US…

ActavisAnalgesiaBuprenorphineButransGenericsLegalPurdue PharmaRegulationUSA

1 to 9 of 30 results

COMPANY SPOTLIGHT

Menarini

Back to top